Ariana appoints Dr Mariana Kuras as chief technology officer

CTO appointment reinforces senior management expertise in biomarker industry

22-Aug-2012 - France

Ariana Pharma announced that it has appointed Dr. Mariana Kuras as its chief technology officer.

Mariana brings to Ariana eight years of experience at Biosystems International. Whilst director of research, she was responsible for the development and validation of biomarker platform technologies in multi-million euro projects. These technologies included the application of antibodies to various diseases, including oncology and neurodegenerative diseases. Mariana and her team contributed towards the development of thousands of antibodies used on microarrays and to the patenting and publication of biomarker signatures and paving their route to market.

As a genomics and bioinformatics scientist at Pfizer Global Research and Development, Fresnes, France, Mariana has also been responsible for genomic studies. She has also been an independent scientific expert for the sixth and seventh framework of the European Commission and vice-chair for the life sciences panel for sixth PCRD of the research and training networks for the European Commission. She was awarded a PhD in biophysics and computational biology from the University of Illinois at Urbana–Champaign, USA.

Other news from the department people

More news from our other portals

All FT-IR spectrometer manufacturers at a glance